| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.07 |